You are here

  • Home
  • Archive
  • Volume 104, Issue 1
  • PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer

Article metrics

Article menu
Download PDFPDF
Original article
PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer

 

Online download statistics by month:

Online download statistics by month: May 2018 to April 2025

AbstractFullPdf
May 20184665076
Jun 20181271114
Jul 2018891611
Aug 201859137
Sep 201873169
Oct 20188596
Nov 2018121116
Dec 20183554826
Jan 20192685938
Feb 2019120198
Mar 20191271410
Apr 20194164
May 20195855
Jun 2019431110
Jul 2019701110
Aug 20196396
Sep 20196835
Oct 2019721810
Nov 201992117
Dec 201910283
Jan 20209778
Feb 2020117145
Mar 20205172
Apr 20203830
May 20208093
Jun 20206155
Jul 20207424
Aug 20203400
Sep 20206663
Oct 20202513
Nov 20205755
Dec 20203811
Jan 20215743
Feb 20217834
Mar 20216621
Apr 20215032
May 20212674
Jun 20211296
Jul 2021523
Aug 20211925
Sep 2021522
Oct 20216750
Nov 20217321
Dec 202110042
Jan 20224831
Feb 20223540
Mar 202263133
Apr 202291126
May 202211067
Jun 20228062
Jul 20226872
Aug 202211684
Sep 20226731
Oct 20229982
Nov 20229140
Dec 20224852
Jan 20237995
Feb 202358110
Mar 20235682
Apr 20234020
May 20234711
Jun 20235820
Jul 20233231
Aug 20233330
Sep 20237731
Oct 20233851
Nov 20235585
Dec 20235454
Jan 20249460
Feb 20247494
Mar 20242124
Apr 20246843
May 20242954
Jun 20245862
Jul 20242001
Aug 20245424
Sep 20245421
Oct 20247663
Nov 20244882
Dec 20241786
Jan 20256631
Feb 20251920
Mar 2025973
Apr 2025900
Total6054662431